Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 9/20 | 0.40 |
| ▸ | ADH1C | P00326 | 6/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | PHGDH | O43175 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14855292 | 1.00 | ADH1A (0.40) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL10013012 | 1.00 | ADH1A (0.40) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL8745529 | 1.00 | ADH1A (0.40) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL10012568 | 1.00 | ADH1A (0.40) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL10913205 | 1.00 | ADH1A (0.40) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL5122415 | 0.97 | ADH1A (0.44) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL3160126 | 0.97 | ADH1A (0.39) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL14855664 | 0.97 | ADH1A (0.39) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL6005192 | 0.94 | ADH1A (0.42) | ADH1AADH1CADH4ALDH1A1ADH1B | |
| SCHEMBL4496316 | 0.94 | ADH1A (0.36) | ADH1AADH1CADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0752452-B1 | Hydroxyquinolone-monoazo dyes, their preparation and use | DYSTAR TEXTILFARBEN GMBH & CO (DE) | 2001-09-12 | — | — | EP | claimed |
| US-5760197-A | YELLOW PIGMENT FOR DYEING TEXTILES | DYSTAR JAPAN LTD. (JP) | 1998-06-02 | — | — | US | claimed |
| EP-0752452-A1 | Hydroxyquinolone-monoazo dyes, their preparation and use | DyStar Japan Ltd. (JP) | 1997-01-08 | — | — | EP | claimed |
| EP-0152759-B1 | AMINOISOTHIAZOLE COMPOUNDS | BASF Aktiengesellschaft (DE) | 1989-08-23 | — | — | EP | claimed |
| EP-0150034-B1 | DERIVATIVES OF 2-AMINOTHIOPHENE | BASF Aktiengesellschaft (DE) | 1989-08-02 | — | — | EP | claimed |
| US-4785116-A | Aminoisothiazole compounds | BASF AKTIENGESELLSCHAFT (DE) | 1988-11-15 | — | — | US | claimed |
| US-4640892-A | STORAGE STABLE BASE PRECURSOR | FUJI PHOTO FILM CO., LTD. (JP) | 1987-02-03 | — | — | US | claimed |
| WO-2024128000-A1 | ISOPOLYOXOTUNGSTATE SALT COMPOUND, SOLVATE THEREOF OR MIXTURE OF SAID COMPOUND AND SOLVATE, AND METHOD FOR PRODUCING SAID COMPOUND, SOLVATE OR MIXTURE | 東京応化工業株式会社 | 2024-06-20 | — | — | WO | disclosed |
| EP-4364739-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING KIDNEY INJURY, AND AUTOPHAGY ACTIVATOR | OSAKA UNIVERSITY (JP) | 2024-05-08 | — | — | EP | disclosed |
| US-11976062-B2 | Benzisoxazole compound | OSAKA UNIVERSITY (JP) | 2024-05-07 | — | — | US | disclosed |
| WO-2024070432-A1 | LIQUID CRYSTAL COMPOSITION, OPTICALLY ANISOTROPIC FILM, OPTICAL FILM, POLARIZING PLATE, IMAGE DISPLAY DEVICE AND POLYMERIZABLE COMPOUND | 富士フイルム株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2024070691-A1 | LAMINATE, IMAGE DISPLAY DEVICE, OPTICAL DEVICE, AND HEAD-MOUNTED DISPLAY | 富士フイルム株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2024043261-A1 | AZO COMPOUND OR SALT THEREOF, AND POLARIZING FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE COMPRISING SAME | 日本化薬株式会社 | 2024-02-29 | — | — | WO | disclosed |
| US-4343811-A | ATHEROSCLEROSIS | BOEHRINGER INGELHEIM GMBH (DE) | 1982-08-10 | — | — | US | disclosed |
| US-4252943-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1981-02-24 | — | — | US | disclosed |
| US-4225617-A | PSYCHOTROPIC AGENTS | LABORATOIRE L. LAFON (FR) | 1980-09-30 | — | — | US | disclosed |
| EP-0015523-A1 | Indole derivatives, their preparation and their use for medicaments | Dr. Karl Thomae GmbH (DE) | 1980-09-17 | — | — | EP | disclosed |
| US-4217359-A | HYPOTENSIVE | E. R. SQUIBB & SONS, INC. (US) | 1980-08-12 | — | — | US | disclosed |
| US-4183951-A | PSYCHOTROPIC AGENTS | LABORATOIRE L. LAFON (FR) | 1980-01-15 | — | — | US | disclosed |
| US-4074057-A | HYPERLIPEMIA, DIABETES | TAKEDA CHEMICAL CO., LTD. (JA) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11976062-B2 | Benzisoxazole compound | CBR1, CYP2S1, CYP2E1 | ADH1A 714/4885ADH1C 1167/4885ADH4 1101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.